MPN Podcast Pilot Study
NCT03907774 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39
Last updated 2020-03-27
Summary
Enrolled MPN patients will participate in a podcast intervention via a smartphone app. They will listen to 60 minutes per week of podcasts through this app, which consist of cancer-related health education material. Participants have the option to listen to additional podcasts beyond the 60-minute weekly prescription if they desire. Participation will be tracked through self-report logs. In addition, questionnaires will be administered at baseline, midpoint (week 6), and post-intervention (week 12), which ask about demographics, health information, and satisfaction. The hypothesis is that the smartphone app is feasible for delivering home-based health education podcasts to MPN patients.
Conditions
- Myeloproliferative Neoplasm, Unclassifiable
Sponsors & Collaborators
-
Arizona State University
lead OTHER
Principal Investigators
-
Jennifer Huberty, PhD · Arizona State University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-06-01
- Primary Completion
- 2019-11-24
- Completion
- 2019-11-24
Countries
- United States
Study Locations
More Related Trials
-
Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy
NCT06510868 ·Status: RECRUITING
-
Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia
NCT02856204 ·Status: COMPLETED
-
Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia
NCT01918241 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
NCT00014456 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib)
NCT05709158 ·Status: UNKNOWN
-
Correlation of Timing of Pegfilgrastim Administration and PIBP.
NCT05841186 ·Status: RECRUITING ·Phase: NA
-
Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.
NCT01813721 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)
NCT03011372 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®
NCT01735175 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy
NCT00117624 ·Status: COMPLETED ·Phase: PHASE3
-
Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia
NCT00503854 ·Status: COMPLETED
-
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
NCT00726934 ·Status: COMPLETED ·Phase: NA
-
The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy
NCT02905916 ·Status: UNKNOWN ·Phase: PHASE4
-
Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer
NCT01724866 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparative Evaluation of Pharmacokinetics and Immunogenicity.
NCT06918587 ·Status: COMPLETED ·Phase: PHASE1
-
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)
NCT02393248 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy
NCT04477616 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment for Elderly Patients With High Risk Breast Cancer
NCT00117910 ·Status: COMPLETED ·Phase: PHASE3
-
Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy
NCT00035594 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation and Modeling of the Effect of G-CSF on the Evolution of Polynuclear Neutrophils During Dense Dose Epirubicin-Cyclophosphamide Regeneration
NCT05296317 ·Status: COMPLETED ·Phase: NA
-
Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3
NCT03102606 ·Status: COMPLETED ·Phase: PHASE3
-
Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
NCT01484015 ·Status: COMPLETED ·Phase: PHASE1
-
Plinabulin iv Solution in Prevention of TAC Induced Neutropenia
NCT04227990 ·Status: COMPLETED ·Phase: PHASE2
-
Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy
NCT00115206 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia
NCT05311254 ·Status: UNKNOWN ·Phase: PHASE3